Modified carbazoles as therapeutic agents
US11420967B2 · kind B2 · utility
0Cited by
1References
24Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 12, 2019 |
| Grant date | Aug 23, 2022 |
| Priority date | — |
| Expiry date | Jul 2, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This disclosure relates to compounds that target microtubules, pharmaceutical compositions comprising them, and methods of using the compounds and compositions for treating diseases. More particularly, this disclosure relates to modified carbazole compounds and pharmaceutical compositions thereof, methods of targeting microtubules with these compounds, and methods of treating diseases affected by microtubule disruption.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.